Imunon Inc (IMNN)
0.9799
+0.03
(+3.15%)
USD |
NASDAQ |
Nov 04, 16:00
0.98
0.00 (0.00%)
After-Hours: 06:26
Imunon Total Assets (Quarterly): 9.692M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 9.692M |
March 31, 2024 | 14.32M |
December 31, 2023 | 21.92M |
September 30, 2023 | 24.65M |
June 30, 2023 | 28.72M |
March 31, 2023 | 42.11M |
December 31, 2022 | 43.98M |
September 30, 2022 | 60.53M |
June 30, 2022 | 65.33M |
March 31, 2022 | 64.34M |
December 31, 2021 | 74.05M |
September 30, 2021 | 79.47M |
June 30, 2021 | 83.01M |
March 31, 2021 | 73.04M |
December 31, 2020 | 37.53M |
September 30, 2020 | 37.27M |
June 30, 2020 | 46.72M |
March 31, 2020 | 38.94M |
December 31, 2019 | 38.28M |
September 30, 2019 | 40.56M |
June 30, 2019 | 43.59M |
March 31, 2019 | 45.40M |
December 31, 2018 | 46.86M |
September 30, 2018 | 40.91M |
June 30, 2018 | 49.51M |
Date | Value |
---|---|
March 31, 2018 | 44.00M |
December 31, 2017 | 47.51M |
September 30, 2017 | 26.00M |
June 30, 2017 | 29.66M |
March 31, 2017 | 30.80M |
December 31, 2016 | 30.85M |
September 30, 2016 | 37.46M |
June 30, 2016 | 43.51M |
March 31, 2016 | 43.33M |
December 31, 2015 | 49.03M |
September 30, 2015 | 53.66M |
June 30, 2015 | 60.41M |
March 31, 2015 | 59.78M |
December 31, 2014 | 66.69M |
September 30, 2014 | 73.57M |
June 30, 2014 | 79.58M |
March 31, 2014 | 54.71M |
December 31, 2013 | 45.67M |
September 30, 2013 | 47.43M |
June 30, 2013 | 51.01M |
March 31, 2013 | 47.96M |
December 31, 2012 | 25.36M |
September 30, 2012 | 25.41M |
June 30, 2012 | 26.54M |
March 31, 2012 | 27.04M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.692M
Minimum
Jun 2024
83.01M
Maximum
Jun 2021
46.52M
Average
42.11M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
Merck & Co Inc | 112.63B |
Cormedix Inc | 77.59M |
Brainstorm Cell Therapeutics Inc | 5.683M |
Predictive Oncology Inc | 10.59M |
Outlook Therapeutics Inc | 47.09M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 5.950M |
Shareholders Equity (Quarterly) | 3.741M |